Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 40 (9) , 745-751
Abstract
The natural history of oncogenic human papillomavirus (HPV) infections results from interactions of the virus, the host, and multiple cofactors. We studied the association between humoral immune response to HPV and smoking in 191 HPV infected women prospectively. Two follow-up samples (first and last) were analysed for serum cotinine levels, IgA and IgG antibodies to HPV16 and 18, and Chlamydia trachomatis using ELISA methods. HPV DNA analyses were also performed, and HPV16/18 antibodies were detectable in 23 of 40 (57.5%) HPV DNA-positive women. We performed age-stratified analyses and found that young smokers were less likely to develop HPV16/18 antibodies than non-smokers (OR: 0.2, 95% CI 0.0–0.9). Furthermore, they had a significantly decreased tendency of maintaining constant HPV16/18 IgG antibody positivity by the end of the follow-up (OR: 0.1, 95% CI 0.0–0.8). Smoking did not affect the development of HPV antibody responses in women over 30 y of age. Our results suggest that smoking may induce impaired antibody response in HPV16/18-infected young women.Keywords
This publication has 24 references indexed in Scilit:
- Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CINEuropean Journal of Epidemiology, 2007
- Chapter 13: Current findings from prophylactic HPV vaccine trialsVaccine, 2006
- Serum Cotinine Level as Predictor of Lung Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2006
- Smokers at Higher Risk for Undetected Antibody for Oncogenic Human Papillomavirus Type 16 InfectionCancer Epidemiology, Biomarkers & Prevention, 2006
- High prevalence of HPV among female students in FinlandScandinavian Journal of Infectious Diseases, 2005
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- Comparison of Human Papillomavirus Types 16, 18, and 6 Capsid Antibody Responses Following Incident InfectionThe Journal of Infectious Diseases, 2000
- Type Specificity and Significance of Different Isotypes of Serum Antibodies to Human Papillomavirus CapsidsThe Journal of Infectious Diseases, 2000
- Stability over Time of Serum Antibody Levels to Human Papillomavirus Type 16The Journal of Infectious Diseases, 1998
- Comparison of Development of Serum Antibodies to HPV16 and HPV33 and Acquisition of Cervical HPV DNA Among Sexually Experienced and Virginal Young GirlsSexually Transmitted Diseases, 1996